Skip to content

A Method for Measuring Dissociative Effects of Sub-Anesthetic Doses of Ketamine in Juvenile Female Rats.

Alexis M Klinner, David S Middlemas

Chronic stress (Thousand Oaks, Calif.) January 1, 2026 DOI: 10.1177/24705470261451166 via PubMed

Summary

AI-generated from the abstract

In a female pre-pubescent rat model, sub-anesthetic doses of ketamine (40, 50, and 60 mg/kg) produced dissociative behaviors such as circling and ataxia. Higher doses led to increased severity and longer duration of these effects, lasting up to 120 minutes after injection. The findings suggest a link between ketamine's dissociative effects and its rapid-acting antidepressant action, with higher doses associated with more pronounced dissociation. Further research on long-term dissociative effects is needed to understand the therapeutic risks of using ketamine for adolescent depression.

Study at a glance

Characteristics Preclinical animal study Peer reviewed
Population Female pre-pubescent rats
Intervention Ketamine
Dose 40, 50, and 60 mg/kg
Duration Up to 120 minutes post-injection
Topics Depression Ketamine
Keywords Dissociative effects Juvenile
Key finding Higher sub-anesthetic doses of ketamine intensified both the severity and duration of dissociative behaviors in a female pre-pubescent rat model.

Abstract

Treatment-resistant juvenile depression is a globally prevalent issue, with a need for better pharmacotherapy. Typically, Selective Serotonin Reuptake Inhibitors are front line, but recently there is interest in examining using ketamine or esketamine adjunct in adolescents. In this study, a novel method is used to explore the adverse effects of sub-anesthetic doses of ketamine in a female pre-pubescent rat model, to assess its potential clinical implications. We assessed the severity and duration of dissociative behavior at three sub-anesthetic doses of ketamine (40, 50, and 60 mg•kg-1). Dissociative behaviors cause a subject to feel apart from their reality and ketamine is often abused for such effects. Dissociative behaviors, such as circling and ataxia, were observed following ketamine administration, with higher doses leading to increased severity and duration of symptoms up to 120 min post-injection. Our findings revealed that increasing doses of ketamine intensified both the severity and duration of dissociative behaviors. In conclusion, these results suggest a correlation underlying ketamine's rapid-acting antidepressant effect, particularly with higher sub-anesthetic doses associated with more pronounced dissociative behaviors and a rapid-acting antidepressant effect. Further investigation into ketamine's impact on longer-term dissociative effects is warranted to deepen our understanding of its therapeutic risks of ketamine treatment of adolescent depression.

Explore topics

Comments

No comments yet.

Log in to comment